What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Toxoplasmosis in Cats: Risks During Pregnancy and Prevention

Etiology and Parasite Biology

Toxoplasmosis is caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. The parasite exists in three infectious stages: tachyzoites, bradyzoites (within tissue cysts), and sporozoites (within oocysts). Felidae, including domestic cats, serve as the definitive host in which sexual reproduction occurs in the intestinal epithelium, leading to the shedding of unsporulated oocysts in feces. All warm-blooded vertebrates, including humans and rodents, act as intermediate hosts, harboring the tachyzoite and bradyzoite stages [1]. The only definitive hosts are members of the family Felidae, making the cat the primary source of environmental contamination with oocysts [2].

The life cycle begins when a cat ingests tissue cysts from an intermediate host, typically a rodent or bird. In the feline small intestine, bradyzoites excyst, invade enterocytes, and undergo multiple rounds of asexual schizogony followed by sexual gametogony. Oocysts are formed and shed in the feces. Shedding begins 3-10 days after primary infection and persists for 1-3 weeks, with an output that can reach several million oocysts per day. Once shed, oocysts sporulate in the environment within 1-5 days under favorable conditions of temperature and humidity, becoming infective to intermediate hosts. Oocysts are extremely resilient and can survive in soil, water, and on surfaces for months to years.

Epidemiology and Transmission Dynamics

Seroprevalence of T. gondii in domestic cats varies widely by geographic region, management practices, and age. Outdoor cats that hunt have higher seroprevalence compared to indoor-only cats. Transmission to cats can occur via ingestion of infected intermediate hosts (primary route), ingestion of sporulated oocysts from the environment, or vertical transmission (transplacental). Kittens may acquire infection transplacentally or via ingestion of milk containing tachyzoites.

The risk of human infection from cats is often overestimated. Direct handling of a cat is not the primary route of transmission to humans; rather, ingestion of sporulated oocysts from contaminated soil, water, or unwashed produce is more common. However, the link between cat toxoplasmosis baby risk is well established through environmental contamination. Pregnant women who are seronegative are at risk of primary infection, which can lead to congenital toxoplasmosis in the fetus, with outcomes ranging from subclinical infection to severe neurological and ocular disease [3].

Clinical Signs in Cats

Most immunocompetent cats infected with T. gondii remain subclinical. Clinical disease is more common in young kittens and immunosuppressed cats (e.g., FIV-positive, FeLV-positive, or those receiving immunosuppressive therapies). The most frequently reported clinical signs are nonspecific: fever, lethargy, anorexia, and weight loss. Organ-specific signs depend on the distribution of tachyzoites.

Ocular toxoplasmosis is common in cats and manifests as uveitis, chorioretinitis, or anterior chamber inflammation. Neurological signs include ataxia, seizures, circling, head pressing, and behavioral changes (for a detailed discussion, refer to Toxoplasmosis in Cats: Neurological Symptoms, Cytology, Pregnancy Risks, and Veterinary Care). Respiratory signs such as dyspnea and coughing occur when pulmonary tissue is involved. Hepatic involvement leads to icterus, and pancreatic involvement can cause vomiting and abdominal pain. Myocarditis may result in arrhythmias or sudden death.

Pathology and Pathogenesis

After ingestion of bradyzoites or oocysts, the parasite invades the intestinal mucosa and disseminates via the bloodstream and lymphatics as tachyzoites. Tachyzoites replicate intracellularly within any nucleated cell, causing cell lysis and focal necrosis. In the definitive host, sexual replication in enterocytes leads to oocyst formation. The immune response (cell-mediated, particularly Th1) eventually controls tachyzoite replication, and the parasite encysts as bradyzoites in tissues such as skeletal muscle, myocardium, brain, and retina. Cysts persist for the life of the host and can reactivate if immunosuppression occurs.

Gross pathology findings are variable and include lymphadenomegaly, splenomegaly, hepatomegaly, and necrotic foci in affected organs. Histologically, acute infections show areas of necrosis with free tachyzoites, while chronic infections reveal tissue cysts with minimal inflammation.

Diagnostic Approaches

Definitive diagnosis of toxoplasmosis in cats requires detection of the organism or its DNA. Serology is the most common screening method, but it does not differentiate recent from past infection unless paired titers or IgM detection is used.

Serology: Indirect immunofluorescence assays (IFA), modified agglutination tests (MAT), and commercial enzyme-linked immunosorbent assays (ELISA) detect IgG and IgM antibodies. A fourfold rise in IgG titers or the presence of IgM suggests recent infection. However, IgM can persist for months. The Sabin-Feldman dye test is a gold standard in reference laboratories but is rarely used in practice.
Detection of oocysts in feces: Fecal flotation and centrifugation, often combined with Sheather's sugar solution, can identify oocysts. Oocysts are 10-12 μm in diameter and closely resemble those of Hammondia hammondi or Besnoitia species, requiring molecular confirmation.
PCR (polymerase chain reaction): Real-time PCR assays targeting the B1 gene or 529 bp repeat element are highly sensitive and specific for detecting T. gondii DNA in blood, aqueous humor, cerebrospinal fluid (CSF), or tissue biopsies. PCR is the test of choice for ocular and neurological cases.
Histopathology and cytology: Immunohistochemistry using specific antibodies can identify tachyzoites and cysts in tissue sections. Cytologic examination of CSF, bronchoalveolar lavage fluid, or aspirates from lymph nodes or organs may reveal tachyzoites.
Bioassay: Inoculation of suspect tissue into mice or cats is considered highly sensitive but is rarely justified for clinical cases.

A diagnostic workflow for suspected feline toxoplasmosis is presented below.

graph TD
    A("Suspected feline toxoplasmosis"), > B{"Clinical signs"}
    B, >|"Ocular/Neuro signs"| C("Collect aqueous humor or CSF")
    B, >|"Systemic signs"| D("Blood sample & fecal sample")
    C, > E("PCR + serology (IgG, IgM)")
    D, > F("Serology, CBC, biochemistry")
    F, > G{"Serology results"}
    G, >|"IgM positive or 4-fold titer rise"| H("Presumptive diagnosis")
    G, >|"IgG only, low titer"| I("Past infection; clinical signs may be unrelated")
    E, > J{"PCR positive?"}
    J, >|"Yes"| K("Confirmed active infection")
    J, >|"No"| L("Consider other etiologies")
    H, > M("Treat with clindamycin or trimethoprim-sulfonamide")
    K, > M
    M, > N("Monitor clinical response")
    N, > O("Re-evaluate in 2-4 weeks")

Treatment and Clinical Management

Antiprotozoal therapy is indicated for cats with clinical signs consistent with toxoplasmosis and a laboratory-confirmed diagnosis. The first-line drug is clindamycin (10-12 mg/kg PO or IM every 12 hours for 4 weeks). Alternative agents include trimethoprim-sulfonamide combinations (15 mg/kg PO every 12 hours) or ponazuril (20 mg/kg PO every 24 hours for 3-5 days). Pyrimethamine and sulfonamides can be used but are less tolerated.

Supportive care includes fluid therapy, nutritional support, and treatment of secondary infections. Immunosuppressive drugs (e.g., glucocorticoids) are contraindicated during active infection unless absolutely necessary for managing immune-mediated inflammation, such as severe ocular uveitis, and should be used cautiously.

Oocyst shedding in cats is transient. Treatment with clindamycin does not reliably eliminate shedding. To reduce shedding, ponazuril or other coccidiostats may be administered during the patent period, but this is rarely necessary unless the cat is in a household with pregnant women.

Risks During Pregnancy

Human Health Context

Primary maternal infection with T. gondii during pregnancy can result in transplacental transmission to the fetus. The risk of transmission increases with gestational age, but the severity of fetal disease is highest when infection occurs in the first trimester. Sequelae of congenital toxoplasmosis include chorioretinitis, hydrocephalus, intracranial calcifications, and intellectual disability.

The Role of the Cat

Cats are directly responsible for contaminating the environment with oocysts. Pregnant women who are seronegative for T. gondii should avoid contact with cat feces, litter boxes, and soil that may be contaminated. It is crucial to note that the cat itself does not need to be physically handled to pose a risk; rather, the persistence of oocysts in the environment is the key exposure route. An indoor cat that has never hunted and is fed only cooked or commercial food presents negligible risk of shedding oocysts.

For more detailed discussion of the cat-to-human transmission dynamics, see Toxoplasmosis in Cats: Zoonotic Risks and Feline Love and Toxoplasmosis in Cats: Life Cycle, Zoonotic Risk, and Prevention.

Prevention Strategies

Prevention in the Cat

The goal of prevention in cats is to minimize the risk of oocyst shedding and subsequent environmental contamination. Practical measures include:

Feed cats only cooked, commercially processed, or frozen-thawed food. Raw meat diets are a major risk factor for acquisition and shedding.
Prevent hunting behavior by keeping cats indoors.
Regularly clean litter boxes daily. Oocysts require 1-5 days to sporulate and become infective; daily removal of feces significantly reduces the risk of sporulation. Dispose of litter in sealed bags.
Wash litter boxes with hot water (>70°C) weekly to inactivate oocysts. Avoid using bleach, as it is ineffective against oocysts.
In multi-cat households, new cats should be quarantined and screened serologically.

Prevention in Pregnant Women (cat owners)

Specific recommendations for households with pregnant women include:

Assign litter box duty to another household member. If impossible, wear disposable gloves and wash hands immediately after cleaning.
Wear gardening gloves when handling soil or sand that may contain cat feces.
Avoid adopting or handling stray cats during pregnancy.
Wash hands thoroughly after any contact with cats or their environment.
Cover children's sandboxes to prevent cat defecation.
Consume only thoroughly cooked meat and wash fruits and vegetables.

For more on indoor-only cat risk, refer to Toxoplasmosis in Cats: Indoor Risk, Transmission, and Zoonotic Prevention and Indoor Cat Toxoplasmosis Risk: Transmission, Clinical Signs, and Prevention. The link between cat toxoplasmosis baby exposure is best mitigated by adherence to these hygiene practices.

Vaccination

No commercial vaccine for T. gondii is currently available for cats in most countries. Experimental vaccines using live-attenuated strains have shown promise in reducing oocyst shedding but are not yet licensed.

Zoonotic Risk Communication

Veterinarians play a key role in educating clients about the realistic zoonotic risks associated with cat toxoplasmosis. The perception that direct contact with cats is the primary risk is inaccurate. The majority of human infections arise from ingestion of undercooked meat (containing tissue cysts) or from accidental ingestion of sporulated oocysts in the environment. Pregnant women need not surrender their cats if proper hygiene is maintained. Tests for T. gondii in cats are commercially available, but a positive IgG result indicates prior infection and negligible ongoing shedding risk, whereas a negative result indicates susceptibility, so the cat should be kept indoors and fed a non-raw diet.

For further reading on zoonotic risks and public health, see Toxoplasmosis in Cats: Zoonotic Risk and Clinical Management and Toxoplasmosis in Cats: Shedding, Diagnosis, and Public Health Risks.

References

[1] Dubey JP. Toxoplasmosis of Animals and Humans. CRC Press.

[2] Greene CE. Infectious Diseases of the Dog and Cat. Elsevier.

[3] Merck Veterinary Manual. Toxoplasmosis in Cats.

[4] World Health Organization. Toxoplasmosis Fact Sheet.

[5] Lappin MR. Feline Toxoplasmosis. In: August JR, editor. Consultations in Feline Internal Medicine. Elsevier. I will keep it simple. Since no specific papers were provided, this is the safest. I'll now write the full article.-- title: "Toxoplasmosis in Cats: Risks During Pregnancy and Prevention" category: "pet-parasites" metaDescription: "A comprehensive veterinary reference on Toxoplasma gondii in cats: etiology, life cycle, zoonotic risk to human pregnancy, clinical signs, diagnostics, treatment, and evidence-based prevention strategies for cat owners and clinicians." primaryKeyword: "toxoplasmosis cats pregnancy prevention" secondaryKeywords: ["cat toxoplasmosis baby", "Toxoplasma gondii feline", "congenital toxoplasmosis prevention", "feline protozoal infection", "zoonotic risk cat litter"] --- # Toxoplasmosis in Cats: Risks During Pregnancy and Prevention ## Etiology and Parasite Biology Toxoplasmosis is caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. The parasite exists in three infectious stages: tachyzoites, bradyzoites (within tissue cysts), and sporozoites (within oocysts). Felidae, including domestic cats, serve as the definitive host in which sexual reproduction occurs in the intestinal epithelium, leading to the shedding of unsporulated oocysts in feces. All warm-blooded vertebrates, including humans and rodents, act as intermediate hosts, harboring the tachyzoite and bradyzoite stages [1]. The only definitive hosts are members of the family Felidae, making the cat the primary source of environmental contamination with oocysts [2]. The life cycle begins when a cat ingests tissue cysts from an intermediate host, typically a rodent or bird. In the feline small intestine, bradyzoites excyst, invade enterocytes, and undergo multiple rounds of asexual schizogony followed by sexual gametogony. Oocysts are formed and shed in the feces. Shedding begins 3-10 days after primary infection and persists for 1-3 weeks, with an output that can reach several million oocysts per day. Once shed, oocysts sporulate in the environment within 1-5 days under favorable conditions of temperature and humidity, becoming infective to intermediate hosts. Oocysts are extremely resilient and can survive in soil, water, and on surfaces for months to years. ## Epidemiology and Transmission Dynamics Seroprevalence of T. gondii in domestic cats varies widely by geographic region, management practices, and age. Outdoor cats that hunt have higher seroprevalence compared to indoor-only cats. Transmission to cats can occur via ingestion of infected intermediate hosts (primary route), ingestion of sporulated oocysts from the environment, or vertical transmission (transplacental). Kittens may acquire infection transplacentally or via ingestion of milk containing tachyzoites. The risk of human infection from cats is often overestimated. Direct handling of a cat is not the primary route of transmission to humans; rather, ingestion of sporulated oocysts from contaminated soil, water, or unwashed produce is more common. However, the link between cat toxoplasmosis baby risk is well established through environmental contamination. Pregnant women who are seronegative are at risk of primary infection, which can lead to congenital toxoplasmosis in the fetus, with outcomes ranging from subclinical infection to severe neurological and ocular disease [3]. ## Clinical Signs in Cats Most immunocompetent cats infected with T. gondii remain subclinical. Clinical disease is more common in young kittens and immunosuppressed cats (e.g., FIV-positive, FeLV-positive, or those receiving immunosuppressive therapies). The most frequently reported clinical signs are nonspecific: fever, lethargy, anorexia, and weight loss. Organ-specific signs depend on the distribution of tachyzoites. Ocular toxoplasmosis is common in cats and manifests as uveitis, chorioretinitis, or anterior chamber inflammation. Neurological signs include ataxia, seizures, circling, head pressing, and behavioral changes (for a detailed discussion, refer to Toxoplasmosis in Cats: Neurological Symptoms, Cytology, Pregnancy Risks, and Veterinary Care). Respiratory signs such as dyspnea and coughing occur when pulmonary tissue is involved. Hepatic involvement leads to icterus, and pancreatic involvement can cause vomiting and abdominal pain. Myocarditis may result in arrhythmias or sudden death. ## Pathology and Pathogenesis After ingestion of bradyzoites or oocysts, the parasite invades the intestinal mucosa and disseminates via the bloodstream and lymphatics as tachyzoites. Tachyzoites replicate intracellularly within any nucleated cell, causing cell lysis and focal necrosis. In the definitive host, sexual replication in enterocytes leads to oocyst formation. The immune response (cell-mediated, particularly Th1) eventually controls tachyzoite replication, and the parasite encysts as bradyzoites in tissues such as skeletal muscle, myocardium, brain, and retina. Cysts persist for the life of the host and can reactivate if immunosuppression occurs. Gross pathology findings are variable and include lymphadenomegaly, splenomegaly, hepatomegaly, and necrotic foci in affected organs. Histologically, acute infections show areas of necrosis with free tachyzoites, while chronic infections reveal tissue cysts with minimal inflammation. ## Diagnostic Approaches Definitive diagnosis of toxoplasmosis in cats requires detection of the organism or its DNA. Serology is the most common screening method, but it does not differentiate recent from past infection unless paired titers or IgM detection is used. * Serology: Indirect immunofluorescence assays (IFA), modified agglutination tests (MAT), and commercial enzyme-linked immunosorbent assays (ELISA) detect IgG and IgM antibodies. A fourfold rise in IgG titers or the presence of IgM suggests recent infection. However, IgM can persist for months. The Sabin-Feldman dye test is a gold standard in reference laboratories but is rarely used in practice. * Detection of oocysts in feces: Fecal flotation and centrifugation, often combined with Sheather's sugar solution, can identify oocysts. Oocysts are 10-12 μm in diameter and closely resemble those of Hammondia hammondi or Besnoitia species, requiring molecular confirmation. * PCR (polymerase chain reaction): Real-time PCR assays targeting the B1 gene or 529 bp repeat element are highly sensitive and specific for detecting T. gondii DNA in blood, aqueous humor, cerebrospinal fluid (CSF), or tissue biopsies. PCR is the test of choice for ocular and neurological cases. * Histopathology and cytology: Immunohistochemistry using specific antibodies can identify tachyzoites and cysts in tissue sections. Cytologic examination of CSF, bronchoalveolar lavage fluid, or aspirates from lymph nodes or organs may reveal tachyzoites. * Bioassay: Inoculation of suspect tissue into mice or cats is considered highly sensitive but is rarely justified for clinical cases. A diagnostic workflow for suspected feline toxoplasmosis is presented below. mermaid graph TD A("Suspected feline toxoplasmosis"), > B{"Clinical signs"} B, >|"Ocular/Neuro signs"| C("Collect aqueous humor or CSF") B, >|"Systemic signs"| D("Blood sample & fecal sample") C, > E("PCR + serology (IgG, IgM)") D, > F("Serology, CBC, biochemistry") F, > G{"Serology results"} G, >|"IgM positive or 4-fold titer rise"| H("Presumptive diagnosis") G, >|"IgG only, low titer"| I("Past infection; clinical signs may be unrelated") E, > J{"PCR positive?"} J, >|"Yes"| K("Confirmed active infection") J, >|"No"| L("Consider other etiologies") H, > M("Treat with clindamycin or trimethoprim-sulfonamide") K, > M M, > N("Monitor clinical response") N, > O("Re-evaluate in 2-4 weeks") ## Treatment and Clinical Management Antiprotozoal therapy is indicated for cats with clinical signs consistent with toxoplasmosis and a laboratory-confirmed diagnosis. The first-line drug is clindamycin (10-12 mg/kg PO or IM every 12 hours for 4 weeks). Alternative agents include trimethoprim-sulfonamide combinations (15 mg/kg PO every 12 hours) or ponazuril (20 mg/kg PO every 24 hours for 3-5 days). Pyrimethamine and sulfonamides can be used but are less tolerated. Supportive care includes fluid therapy, nutritional support, and treatment of secondary infections. Immunosuppressive drugs (e.g., glucocorticoids) are contraindicated during active infection unless absolutely necessary for managing immune-mediated inflammation, such as severe ocular uveitis, and should be used cautiously. Oocyst shedding in cats is transient. Treatment with clindamycin does not reliably eliminate shedding. To reduce shedding, ponazuril or other coccidiostats may be administered during the patent period, but this is rarely necessary unless the cat is in a household with pregnant women. ## Risks During Pregnancy ### Human Health Context Primary maternal infection with T. gondii during pregnancy can result in transplacental transmission to the fetus. The risk of transmission increases with gestational age, but the severity of fetal disease is highest when infection occurs in the first trimester. Sequelae of congenital toxoplasmosis include chorioretinitis, hydrocephalus, intracranial calcifications, and intellectual disability. ### The Role of the Cat Cats are directly responsible for contaminating the environment with oocysts. Pregnant women who are seronegative for T. gondii should avoid contact with cat feces, litter boxes, and soil that may be contaminated. It is crucial to note that the cat itself does not need to be physically handled to pose a risk; rather, the persistence of oocysts in the environment is the key exposure route. An indoor cat that has never hunted and is fed only cooked or commercial food presents negligible risk of shedding oocysts. For more detailed discussion of the cat-to-human transmission dynamics, see Toxoplasmosis in Cats: Zoonotic Risks and Feline Love and Toxoplasmosis in Cats: Life Cycle, Zoonotic Risk, and Prevention. ## Prevention Strategies ### Prevention in the Cat The goal of prevention in cats is to minimize the risk of oocyst shedding and subsequent environmental contamination. Practical measures include: * Feed cats only cooked, commercially processed, or frozen-thawed food. Raw meat diets are a major risk factor for acquisition and shedding. * Prevent hunting behavior by keeping cats indoors. * Regularly clean litter boxes daily. Oocysts require 1-5 days to sporulate and become infective; daily removal of feces significantly reduces the risk of sporulation. Dispose of litter in sealed bags. * Wash litter boxes with hot water (>70°C) weekly to inactivate oocysts. Avoid using bleach, as it is ineffective against oocysts. * In multi-cat households, new cats should be quarantined and screened serologically. ### Prevention in Pregnant Women (cat owners) Specific recommendations for households with pregnant women include: * Assign litter box duty to another household member. If impossible, wear disposable gloves and wash hands immediately after cleaning. * Wear gardening gloves when handling soil or sand that may contain cat feces. * Avoid adopting or handling stray cats during pregnancy. * Wash hands thoroughly after any contact with cats or their environment. * Cover children's sandboxes to prevent cat defecation. * Consume only thoroughly cooked meat and wash fruits and vegetables. For more on indoor-only cat risk, refer to [Toxoplasmosis in Cats: Indoor Risk, Transmission, and Zoonotic Prevention](/knowledge/parasites/pet-par